HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ASA Takes Shears To Hairburst Ad Claims; Volume & Growth Elixir Will Need Name Change

Executive Summary

Hairburst’s hair-growth and hair-loss prevention claims on cosmetic products are inadequately substantiated, and many of the health claims it uses to promote food supplements are unauthorized, the Advertising Standards Authority says in a 14 Aug. decision.

You may also be interested in...



NAD: Firm's Laser Cap Hair-Regrowth Claims Not Supported, Despite FDA Clearance

The Capillus82 Hair Regrowth Laser Cap may be "substantially equivalent" to the manufacturer's Capillus272 Pro device, based on FDA's 510(k) clearance, but NAD says hair-growth clinical findings from that "predicate" device cannot serve to substantiate claims for the untested Capillus82. The case illustrates complexities in the medical device segment, which increasingly is of interest to cosmetics companies.

Hot Chocolate For 'Rapunzel Locks'? UK Ad Watchdog Pounces

The Advertising Standards Authority says Cocoa Locks' hair-growth promises for its hot chocolate mix exceed authorized food health claims registered in the EU. The company’s business may need a major overhaul, down to its brand tagline, “Hair Growth Never Tasted So Good.”

Beiersdorf Is Having Record Year For Sun Care, Seeing China Recovery, But Full-Year Outlook Is Guarded

The Hamburg, Germany-based firm defied economic and political headwinds and China troubles in the fiscal 2022 first half to book organic net sales growth of 10.5% to 4.5bn worldwide. Despite optimism about China recovery, sun care, and its recent Chantecaille acquisition, Beiersdorf is projecting a slowdown in the second half in what remains a volatile operating environment.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS149107

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel